BioSpace News Archive

Press Releases

City Therapeutics Announces $99.5 Million Series B Financing to Advance Next-Generation RNAi Therapeutics

June 9, 2026
·
3 min read
Press Releases

DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026

June 9, 2026
·
8 min read
Press Releases

Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study

June 9, 2026
·
19 min read
Press Releases

Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment

June 9, 2026
·
14 min read
Press Releases

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

June 9, 2026
·
8 min read
Press Releases

Moderna and the University of Oxford Receive UK Authorization to Begin Phase 1/2 Study of Investigational mRNA Cancer Vaccine for People with Lynch Syndrome

June 9, 2026
·
8 min read
Press Releases

China NMPA Grants IND Clearance to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for the Treatment of Late-Stage Solid Tumors, Including Prostate Cancer

June 9, 2026
·
3 min read
Press Releases

Zai Lab Receives China NMPA Approval of TIVDAK® (tisotumab vedotin for injection) for the Treatment of Adult Patients with Recurrent or Metastatic Cervical Cancer

June 9, 2026
·
8 min read
Press Releases

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

June 9, 2026
·
3 min read
Press Releases

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

June 9, 2026
·
5 min read